BRIXADI

• tagApproval1,622 co-mentions · 579 sources
• drugSUBLOCADE1,326 co-mentions · 584 sources
• drugBUTRANS1,296 co-mentions · 584 sources
• drugSUBOXONE1,276 co-mentions · 528 sources
• drugbuprenorphine ER1,270 co-mentions · 584 sources
• drugbuprenorphine1,270 co-mentions · 584 sources
• drugBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE1,236 co-mentions · 528 sources
• drugBUPRENORPHINE HYDROCHLORIDE1,209 co-mentions · 528 sources

Trials studying BRIXADI

• —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
• phase2A Study of Brenipatide in Participants With Opioid Use Disorderrecruitingn=465
• phase4Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.recruitingn=600
• phase1Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadonerecruitingn=32
• phase4Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinicnot yet recruitingn=60
• —Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancyrecruitingn=100
• —Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studycompletedn=71
• —Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-studycompletedn=97